Scott Hensley
Hungarian-born biochemist Katalin Karikó and American immunologist Drew Weissman found that a chemical change to genetic code called mRNA eliminated a problematic side effect when used in vaccines.
In a highly anticipated decision, the Food and Drug Administration authorized Pfizer’s Paxlovid as the first antiviral pill to treat COVID-19 at home.
CDC Director Rochelle Walensky also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.
A third shot of the vaccine can be given at least six months after the two-dose regimen, according to the authorization. A booster rollout could begin this week.
The approval replaces the emergency use authorizations granted last December, and could make it easier for employers, the military and universities to mandate the vaccination.
Two days before a panel of experts is set to review Moderna’s COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 95% effective and well-tolerated.
Experts will assess the benefits and risks of authorizing what could be the first COVID-19 vaccine for emergency use in the U.S.
Trump “has completed his first dose and is resting comfortably,” Sean Conley said in a statement.
Details are scarce, but the companies said they want to help their employees get high-quality health care at a reasonable cost. Will this consortium have better luck than those that have preceded it?
A July letter from Aetna CEO Mark Bertolini to the Justice Department said the company would pull back from health insurance exchanges if the government opposed the company’s merger with Humana.
An NPR poll found that a majority of people favor regulation of e-cigarette. Support rose with education. Nearly two-thirds of people with college or graduate degrees supported regulation.
